BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 33124124)

  • 1. The predictive value of preimplant pulmonary function testing in LVAD patients.
    Hess NR; Seese LM; Hickey GW; Keebler ME; Wang Y; Thoma F; Kilic A
    J Card Surg; 2021 Jan; 36(1):105-110. PubMed ID: 33124124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pulmonary Function Testing and Outcomes after Left Ventricular Assist Device Implantation.
    Raheja S; Nemeh H; Williams C; Tita C; Selektor Y; Chamogeorgiakis T; Lanfear D
    Heart Surg Forum; 2019 May; 22(3):E202-E206. PubMed ID: 31237543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identifying Temporal Relationships Between In-Hospital Adverse Events After Implantation of Durable Left Ventricular Assist Devices.
    Kilic A; Seese L; Pagani F; Kormos R
    J Am Heart Assoc; 2020 Apr; 9(8):e015449. PubMed ID: 32285751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Implications of Respiratory Failure in Patients Receiving Durable Left Ventricular Assist Devices for End-Stage Heart Failure.
    Miller PE; Caraballo C; Ravindra NG; Mezzacappa C; McCullough M; Gruen J; Levin A; Reinhardt S; Ali A; Desai NR; Ahmad T
    Circ Heart Fail; 2019 Nov; 12(11):e006369. PubMed ID: 31707800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preoperative prealbumin does not impact outcomes after left ventricular assist device implantation.
    Hong Y; Seese L; Hickey G; Mathier M; Thoma F; Kilic A
    J Card Surg; 2020 May; 35(5):1029-1036. PubMed ID: 32237175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulmonary function assessment post-left ventricular assist device implantation.
    Sajgalik P; Kim CH; Stulak JM; Kushwaha SS; Maltais S; Joyce DL; Joyce LD; Johnson BD; Schirger JA
    ESC Heart Fail; 2019 Feb; 6(1):53-61. PubMed ID: 30311748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of hepatic steatosis on outcomes after left ventricular assist device implantation.
    Hong Y; Dufendach K; Wang Y; Thoma F; Kilic A
    J Card Surg; 2021 Jul; 36(7):2277-2283. PubMed ID: 33783048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between renal function and left ventricular assist device use.
    Butler J; Geisberg C; Howser R; Portner PM; Rogers JG; Deng MC; Pierson RN
    Ann Thorac Surg; 2006 May; 81(5):1745-51. PubMed ID: 16631666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preoperative renal dysfunction does not affect outcomes of left ventricular assist device implantation.
    Kilic A; Chen CW; Gaffey AC; Wald JW; Acker MA; Atluri P
    J Thorac Cardiovasc Surg; 2018 Sep; 156(3):1093-1101.e1. PubMed ID: 30017440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early Right Ventricular Assist Device Use in Patients Undergoing Continuous-Flow Left Ventricular Assist Device Implantation: Incidence and Risk Factors From the Interagency Registry for Mechanically Assisted Circulatory Support.
    Kiernan MS; Grandin EW; Brinkley M; Kapur NK; Pham DT; Ruthazer R; Rame JE; Atluri P; Birati EY; Oliveira GH; Pagani FD; Kirklin JK; Naftel D; Kormos RL; Teuteberg JJ; DeNofrio D
    Circ Heart Fail; 2017 Oct; 10(10):. PubMed ID: 29021348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of renal replacement therapy in patients with continuous flow left ventricular assist devices.
    Parikh U; Lamba H; Ajmal M; Vincent J; Walther C; Shafii A; Nair A; Civitello A; Liao K; Chatterjee S
    J Artif Organs; 2021 Jun; 24(2):207-216. PubMed ID: 33598826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The aspartate transaminase/alanine transaminase (DeRitis) ratio predicts mid-term mortality and renal and respiratory dysfunction after left ventricular assist device implantation.
    Pilarczyk K; Carstens H; Heckmann J; Canbay A; Koch A; Pizanis N; Jakob H; Kamler M
    Eur J Cardiothorac Surg; 2017 Oct; 52(4):781-788. PubMed ID: 29156019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preoperative Right-Sided Cardiac Congestion Is Associated with Gastrointestinal Bleeding in Patients with Continuous-Flow Left Ventricular Assist Devices.
    Tomizawa Y; Tanaka A; Kitahara H; Sakuraba A; Uriel N; Jeevanandam V; Ota T
    Dig Dis Sci; 2018 Jun; 63(6):1518-1524. PubMed ID: 29417325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significance of Residual Mitral Regurgitation After Continuous Flow Left Ventricular Assist Device Implantation.
    Kassis H; Cherukuri K; Agarwal R; Kanwar M; Elapavaluru S; Sokos GG; Moraca RJ; Bailey SH; Murali S; Benza RL; Raina A
    JACC Heart Fail; 2017 Feb; 5(2):81-88. PubMed ID: 28017353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of adverse events on health-related quality of life after left ventricular assist device implantation: An STS INTERMACS analysis.
    Kilic A; Kwon JH; Grady KL; Singletary BA; Kilic A; Everitt M; Cleveland J; Cantor RS; Blackmon S; Breathett K; McKellar S; Keebler M; Kirklin JK; Stehlik J
    J Heart Lung Transplant; 2023 Sep; 42(9):1214-1222. PubMed ID: 37040860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of age on outcomes following continuous-flow left ventricular assist device implantation.
    Lushaj EB; Badami A; Osaki S; Murray M; Leverson G; Lozonschi L; Akhter S; Kohmoto T
    Interact Cardiovasc Thorac Surg; 2015 Jun; 20(6):743-8. PubMed ID: 25770085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postoperative right ventricular failure after left ventricular assist device placement is predicted by preoperative echocardiographic structural, hemodynamic, and functional parameters.
    Raina A; Seetha Rammohan HR; Gertz ZM; Rame JE; Woo YJ; Kirkpatrick JN
    J Card Fail; 2013 Jan; 19(1):16-24. PubMed ID: 23273590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of Bleeding Revision on Outcomes After Left Ventricular Assist Device Implantation.
    Angleitner P; Simon P; Kaider A; Wiedemann D; Dimitrov K; Schlöglhofer T; Rajek MA; Riebandt J; Laufer G; Zimpfer D
    Ann Thorac Surg; 2019 Aug; 108(2):517-523. PubMed ID: 30851258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delineating Pathways to Death by Multisystem Organ Failure in Patients With a Left Ventricular Assist Device.
    Seese L; Movahedi F; Antaki J; Kilic A; Padman R; Zhang Y; Kanwar M; Burki S; Sciortino C; Keebler M; Hirji S; Kormos R
    Ann Thorac Surg; 2021 Mar; 111(3):881-888. PubMed ID: 32739256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors and Outcomes of Renal Replacement Therapy After Left Ventricular Assist Device Implantation.
    Asleh R; Schettle S; Briasoulis A; Killian JM; Stulak JM; Pereira NL; Kushwaha SS; Maltais S; Dunlay SM
    Mayo Clin Proc; 2019 Jun; 94(6):1003-1014. PubMed ID: 31171114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.